Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.
Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutiérrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M; Chronic Renal Insufficiency Cohort (CRIC) Study Group.
Isakova T, et al. Among authors: wolf m.
JAMA. 2011 Jun 15;305(23):2432-9. doi: 10.1001/jama.2011.826.
JAMA. 2011.
PMID: 21673295
Free PMC article.